Atossa Therapeutics, Inc. (ATOS) has 18 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Guse Kyle mit 557,900 Aktien. Weitere bedeutende Anteilseigner sind Rees Heather und Chen Ben R.
In den letzten 12 Monaten haben Insider 15 Transaktionen in ATOS Aktien getätigt — 14 Käufe (im Wert von $3.24M) und 0 Verkäufe (im Wert von RSU Award). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
ATOS Insider-Beteiligungen
Größter Aktionär
Guse Kyle
557,900 Aktien
Käufe (12 Monate)
14
$3.24M Wert
Verkäufe (12 Monate)
0
$0.00 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Guse Kyle |
CFO, Gen Counsel and Secretary |
557,900 |
2023-03-06 |
|
| 2 |
Rees Heather |
Chief Financial Officer |
543,785 |
2025-05-16 |
|
| 3 |
Chen Ben R |
Sr. VP of Glob. Reg. Affairs |
300,000 |
2014-04-03 |
|
| 4 |
Youmans Scott |
Chief Operating Officer |
286,217 |
2015-09-03 |
|
| 5 |
Cigler Tessa |
Director |
125,000 |
2025-05-16 |
|
| 6 |
Galli Stephen J |
Director |
125,000 |
2025-05-16 |
|
| 7 |
Chen Shu-chih |
Director |
125,000 |
2025-05-16 |
|
| 8 |
Finn Jonathan |
Director |
125,000 |
2025-05-16 |
|
| 9 |
Remmel H. Lawrence |
Director |
125,000 |
2025-05-16 |
|
| 10 |
Steinhart Richard I |
Director |
125,000 |
2025-05-16 |
|
| 11 |
Cross Alexander D |
Director |
88,866 |
2013-06-27 |
|
| 12 |
Quay Steven C |
President & CEO |
88,038 |
2026-03-31 |
|
| 13 |
Daniel Mark James |
Chief Financial Officer |
63,000 |
2026-03-30 |
|
| 14 |
Sawyer John E |
See Remarks |
59,265 |
2015-03-18 |
|
| 15 |
Destro Christopher S. |
SVP, Sales and Marketing |
54,625 |
2015-03-18 |
|
| 16 |
Carbonaro Peter J. |
Sr. Vice President, Operations |
45,000 |
2014-05-08 |
|
| 17 |
Barnhart John |
Director |
44,882 |
2013-05-09 |
|
| 18 |
Weaver Gregory L |
Former EVP, CFO, & Director |
55 |
2023-11-17 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-27 |
Quay Steven C |
President & CEO |
RSU-Zuteilung |
65,000 |
- |
- |
| 2026-03-26 |
Daniel Mark James |
Chief Financial Officer |
RSU-Zuteilung |
63,000 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
RSU-Zuteilung |
331,674 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
RSU-Zuteilung |
325,203 |
- |
- |
| 2025-10-14 |
Daniel Mark James |
Chief Financial Officer |
RSU-Zuteilung |
578,000 |
$1.03 |
$595.34K |
| 2025-10-14 |
Daniel Mark James |
Officer |
Unbekannt |
- |
- |
- |
| 2025-05-21 |
Quay Steven C |
President & CEO |
Informierter Kauf |
11,239 |
$0.88 |
$9.89K |
| 2025-05-15 |
Cigler Tessa |
Director |
RSU-Zuteilung |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Rees Heather |
Chief Financial Officer |
RSU-Zuteilung |
543,785 |
$0.99 |
$538.35K |
| 2025-05-15 |
Finn Jonathan |
Director |
RSU-Zuteilung |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Chen Shu-chih |
Director |
RSU-Zuteilung |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Galli Stephen J |
Director |
RSU-Zuteilung |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Remmel H. Lawrence |
Director |
RSU-Zuteilung |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Steinhart Richard I |
Director |
RSU-Zuteilung |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Quay Steven C |
President & CEO |
RSU-Zuteilung |
1,366,062 |
$0.99 |
$1.35M |
